🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06193980
Recruiting Observational

ICU Combined Assessment of Cardio-Respiratory Exercise

NCT06193980 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2023-12-15
Last updated
2026-06-15

Condition(s) studied

ICU Acquired WeaknessSepsisShockCritical IllnessMicrocirculation

Study summary

This study aims to investigate how sepsis and critical illness can impair the cardiovascular system and microcirculation in intensive care unit (ICU) patients, which can lead to long-lasting muscle weakness/dysfunction or ICU-Acquired Weakness (ICU-AW) and exercise limitations.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients who have received mechanical ventilation for at least 7 days in the intensive care unit (ICU) and have subsequently been discharged from hospital. Exclusion Criteria: * Unable to provide consent * Trajectory of health expected to be significantly limited in the upcoming 12 months * those who self-report that they cannot climb at least one flight of stairs due to limited exercise capacity * have significant orthopedic or musculoskeletal impairment affecting mobility * have a medical history of neuromuscular disease * ongoing respiratory limitations (i.e., supplemental oxygen) * significant heart disease (i.e. ejection fraction less than 30%, unstable ischemic heart disease, severe valvular heart disease) * a body mass index (BMI) of ≥ 40 kg/m2 (impacting NIRS signal due to adipose tissue thickness) * if participant's primary residence is a significant distance from the participating study site

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
St. Boniface General Hospital Winnipeg Manitoba Recruiting
Health Sciences Centre Winnipeg Winnipeg Manitoba Recruiting

More University of Manitoba trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06193980 on ClinicalTrials.gov ↗ ← All trials in Canada